Brand name: Ibrance
Chemical name: Palbociclib
How it works: A kinase is a type of protein in the body that helps control cell division. Ibrance works by inhibiting the kinase and stopping cancer cells from dividing and growing.
Uses: Ibrance is used in combination with an aromatase inhibitor to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that hasn’t been treated with hormonal therapy before in postmenopausal women and men. Arimidex (chemical name: anastrozole), Aromasin (chemical name: exemestane), and Femara (chemical name: letrozole) are aromatase inhibitors.
Ibrance also is approved to be used in combination with Faslodex (chemical name: fulvestrant) to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that has grown after being treated with hormonal therapy in women and men. Premenopausal and perimenopausal women who take Ibrance in combination with Faslodex also should be treated with a medicine to suppress ovarian function.
How it’s given: Ibrance is a pill taken by mouth.
- anemia (low red blood cell count)
- mouth sores
- hair thinning or loss
- decreased appetite
- neutropenia (low white blood cell count)
- blood clots
- severe lung inflammation
Read more about Ibrance.
- Ibrance (palbociclib) prescribing information. Pfizer. New York, NY. 2018. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=2191
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
- Triple-Negative Breast Cancer (Redirect)
What Is Breast Implant Illness?
Breast implant illness (BII) is a term that some women and doctors use to refer to a wide range...